STOCK TITAN

AMETEK INC/ SEC Filings

AME NYSE

Welcome to our dedicated page for AMETEK INC/ SEC filings (Ticker: AME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMETEK INC/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMETEK INC/'s regulatory disclosures and financial reporting.

Rhea-AI Summary

AMETEK chief executive officer David A. Zapico reported several equity-related transactions in the company’s stock. He acquired 32,519 shares of common stock at no cost through the settlement of performance-based restricted stock units awarded on March 22, 2023. To cover associated tax obligations, 12,797 shares were disposed of at a price of $233.33 per share through share withholding rather than an open-market sale. In a separate plan-related adjustment, 76 additional common stock equivalents were credited through dividend reinvestments under the Supplemental Executive Retirement Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK reported record 2025 results, extending its growth model. Sales reached $7.401 billion, up 6.6%, with net income of $1.480 billion and diluted EPS of $6.40, up 7.9% from 2024.

Orders were $7.579 billion and backlog rose to $3.582 billion, supporting future revenue. The Electronic Instruments Group generated $4.919 billion of sales, while Electromechanical Group delivered $2.482 billion with sharply higher margins.

AMETEK generated $1.802 billion of operating cash flow and $1.672 billion of free cash flow, funding $933.2 million of acquisitions (Kern and FARO), $443.0 million of share repurchases and higher dividends, while modestly increasing net debt and maintaining a low net debt-to-capital ratio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

AMETEK Inc. chief commercial officer Julie A. Speranza reported equity award vesting and related tax withholding transactions. On March 21, 2025, 404 shares of common stock were acquired at an exercise price of $0 through the vesting of restricted stock units, and 182 shares were disposed of at $174.52 per share to cover taxes. On March 22, 2025, a further 343 shares were acquired at $0, with 155 shares disposed of at $174.52 per share for tax withholding, as noted in the filing.

Following these transactions, Table I shows 31,970 shares of AMETEK common stock held directly. The footnotes state that the restricted stock units vest in three equal annual installments starting on March 19, 2025 and March 22, 2024, and that Ms. Speranza owned 29,270 shares of common stock as of the date this amendment was filed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AMETEK’s chief commercial officer, Giovanna M. Speranza, reported equity awards and related share movements. On March 18, 2025 she received 890 restricted stock units and 2,720 stock options, each tied to AMETEK common stock at an exercise price of $176.08.

On March 19, 2025, 230 restricted stock units were converted into common stock at $0, and 104 of those shares were withheld at $177.07 per share to cover taxes. After these transactions she directly owned 31,560 AMETEK common shares, plus 890 restricted stock units, 2,720 stock options, and 460 additional restricted stock units subject to vesting schedules beginning March 18, 2026 and March 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK, Inc. announced that its Board of Directors has approved a 10% increase in the quarterly cash dividend on its common stock, raising it to $0.34 per share from $0.31. The first quarter dividend will be payable on March 31, 2026 to shareholders of record as of March 16, 2026.

This increase lifts the company’s indicated annual dividend rate to $1.36 per share, reflecting management’s confidence in AMETEK’s financial strength and ongoing cash generation. The company highlights strong growth, solid cash flow, and a continued focus on strategic acquisitions alongside returning cash to shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
current report
-
Filing
Rhea-AI Summary

AMETEK, Inc. furnished an update on its performance and strategy by sharing two press releases. The company announced its financial results for the twelve months ended December 31, 2025, highlighting what it describes as record fourth quarter and full year results. These details are contained in a press release attached as an exhibit.

AMETEK also reported that it has acquired LKC Technologies, and provided a separate press release with additional information about this transaction. Both releases are furnished, not filed, meaning they are not automatically incorporated into other securities law filings unless specifically referenced.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
current report
Rhea-AI Summary

AMETEK, Inc. insider holdings are reported for a Senior Vice President and Controller as of 01/06/2026. The reporting person holds 43,747 shares of AMETEK common stock directly, plus 711 common stock units in a SERP account and 3,149 common stock units through a 401(k) plan.

The filing also lists stock options on AMETEK common stock. These include options on 583 shares at an exercise price of $138.46 expiring on 03/22/2033, options on 939 shares at $181.93 expiring on 03/19/2034, and options on 1,381 shares at $176.08 expiring on 03/18/2035. Each grant vests in three equal annual installments beginning on its stated start date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK Inc. director reports stock gift

A director of AMETEK Inc. reported a disposition of 1,250 shares of AMETEK common stock on 12/30/2025 coded as "G," indicating a gift transaction. The shares were transferred at a reported price of $0, consistent with a non-cash gift rather than a market sale. Following this transaction, the director beneficially owns 4,690 shares of AMETEK common stock in direct ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK Inc. (AME) senior vice president and comptroller reported a small gift of company stock. On 12/26/2025, the officer transferred 19 shares of Common Stock in a transaction coded “G” (gift) at a reported price of $0 per share.

After this transaction, the officer beneficially owns 22,097 shares held directly in a 401(k) plan, 3,441 shares held indirectly through a 401(k) plan common stock/SERP arrangement, and 3,283 shares held directly outside those plans. The filing reports no derivative securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AMETEK Inc. officer reports option exercise and share sale. A senior vice president and comptroller exercised stock options for 6,388 shares of AMETEK common stock on 12/22/2025 at an exercise price of $85.45 per share and immediately sold 6,388 shares on the same date. The reported sale price is $205.0548 per share, with actual sale prices ranging from $204.57 to $205.49. After these transactions, the reporting person holds 22,116 AMETEK shares directly and 3,441 shares indirectly through a 401(k) plan. The underlying stock options, which were scheduled to become exercisable in three equal annual installments beginning on May 9, 2020, now show a remaining balance of zero and had an expiration date of May 9, 2029.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many AMETEK INC/ (AME) SEC filings are available on StockTitan?

StockTitan tracks 84 SEC filings for AMETEK INC/ (AME), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AMETEK INC/ (AME)?

The most recent SEC filing for AMETEK INC/ (AME) was filed on February 19, 2026.